all patients treated with hyperthermia plus radiotherapy, regardless of the indication
Conditions
Interventions
Group 1: Medical information from all patients treated with a combination of hyperthermia and radiation therapy in Freiburg, and in some cases also with parallel systemic therapies, is systematically
Sponsors
Universitätsklinikum Freiburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - hyperthermia treatment combined with radiotherapy - signed informed consent
Exclusion criteria
Exclusion criteria: inability to consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The objectives of data collection are to create a database in order to: 1. Establish a benefit-risk profile for combination therapy for different tumor entities and locations. 2. determine the influence of temperature on efficacy and tolerability for quality assurance and optimization of hyperthermia therapy. 3. evaluate the radiation treatment regimen and the treatment sequence of hyperthermia and radiation in order to achieve standardization. 4. Investigate the efficacy and tolerability of combination therapies with other therapies (e.g., chemo/hormone/immunotherapy) used in parallel with hyperthermia + radiation. 5. Evaluate the efficacy and tolerability of multiple HT+RT follow-up treatments. | — |
Countries
Germany
Contacts
Public ContactAndreas Thomsen
Universitätsklinikum Freiburg, Klinik für Strahlentherapie
Outcome results
None listed